Phonak EON hearing aid portfolio now available to U.S. military service members

Phonak is proud to announce its next-generation hearing aid platform EON is now available through Veterans Affairs (VA) and the Department of Defense (DOD).

Continue reading at AudiologyOnline

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No actionable clinical change; VA and DoD audiologists should note the Phonak EON platform is now available through both federal systems as an additional prescribing option.

✦ Why It Matters ✦

Simultaneous access through both VA and DoD channels is notable in scope, potentially reaching a larger population of active-duty personnel and veterans than VA-only rollouts.

✦ Key Points ✦

01Phonak EON is available through both the VA and the Department of Defense (DoD) audiology systems.
02The EON is described as a next-generation platform, though specific technical features are not detailed in this announcement.
03Dual-channel federal availability (VA + DoD) is broader than most competing product launches.
04No clinical efficacy or outcomes data are included in this press release.

✦ Claims & Evidence ✦

ClaimEvidenceSupport

Phonak EON is now available through both the U.S. VA and DoD audiology systems.

press releasesupported

Phonak EON is a next-generation hearing aid platform.

press releasepromotional

✦ Related stories ✦

PubMed·Clinical trial·Hearing aids·2mo ago

Unilateral and Bilateral Hearing Aids for Age-Related Hearing Loss: A Randomized Clinical Trial

of this RCT directly bear on bilateral vs. unilateral fitting decisions for adults with symmetrical mild-to-moderate age-related hearing loss; full-text review is essential, but this is potentially practice-changing depending on the direction and magnitude of the findings.

PubMed·Journal article·Hearing aids·2mo ago

Hearing aids for mild to moderate hearing loss in adults

Audiologists should monitor this updated Cochrane review's conclusions closely; if it confirms benefit, it strengthens the case for fitting hearing aids in mild-loss patients who are currently under-served.

PubMed·Journal article·Hearing aids·3mo ago

Digital Interventions for First-Time Hearing Aid Users: A Systematic Review and Meta-Analysis of Efficacy and Effectiveness

Clinicians should consider incorporating evidence-based digital support tools (apps, online programmes) into onboarding protocols for first-time hearing aid users, pending the meta-analysis's specific effect-size findings.

PubMed·Journal article·Hearing aids·6w ago

Self-Fitting Versus Professional-Fitting Hearing Aids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

The meta-analytic findings on self-fitting vs. professional-fitting outcomes should prompt audiologists to review their value proposition and counsel patients on where professional fitting adds measurable benefit, particularly for complex hearing profiles.

PubMed·Journal article·Hearing aids·5mo ago

Individuals with near-normal audiograms but perceived hearing difficulties can achieve aided outcomes on par with those of peers with mild hearing loss

Audiologists should consider fitting hearing aids for patients with near-normal audiograms who report significant hearing difficulty, as aided outcomes can match those of patients with confirmed mild hearing loss.

PubMed·Journal article·Hearing aids·4mo ago

The effect of treating hearing loss with hearing aids on plasma biomarkers of Alzheimer's disease and related dementias

If the study shows hearing-aid use reduces Alzheimer's-related plasma biomarkers, it would strengthen the case for early hearing rehabilitation as a potential dementia-prevention strategy, though findings should be weighed by sample size and study design before changing practice.

PubMed·Journal article·Hearing aids·6mo ago

Hearing Aid Efficacy-Timely Trial Finds Professional Guidance Trumps Costly Tech

This trial supports prioritising high-quality audiological fitting and counselling over premium hearing aid technology alone — audiologists should emphasise their professional value proposition when discussing device options with patients.